10 Best “Strong Buy” Stocks — IPXL GGAL STMP and more

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.

The price of Impax Laboratories, Inc. (IPXL) has seen a 41.9% boost since the first of the year. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.

Since January 1, Grupo Financiero Galicia SA Sponsored ADR Class B (GGAL) has climbed 42.9%. Grupo Financiero Galicia is a financial services holding company. The stock has a trailing PE Ratio of 7.30. For more information, get Portfolio Grader’s complete analysis of GGAL stock.

Since January 1, Stamps.com (STMP) has jumped 48.1%. Stamps.com is an Internet-based company that allows customers to send mail. For more information, get Portfolio Grader’s complete analysis of STMP stock.

Since January 1, China Biologic Products, Inc. (CBPO) has shot up 51.4%. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.

Shares of Ellie Mae, Inc. (ELLI) have risen 51.5% since January 1. Ellie Mae provides business automation software for the mortgage industry in the United States. For more information, get Portfolio Grader’s complete analysis of ELLI stock.

Insperity, Inc. (NSP) has risen 54.5% since the first of the year. Insperity provides personnel management that encompasses a range of services, including benefits and payroll administration, health and workers’ compensation insurance programs and personnel records management. For more information, get Portfolio Grader’s complete analysis of NSP stock.

Shares of Skechers U.S.A., Inc. Class A (SKX) have leaped 78.2% since January 1. Skechers USA designs, makes, markets and distributes footwear. Trade volume rose notably over the past week, up 129.6%. For more information, get Portfolio Grader’s complete analysis of SKX stock.

Since the first of the year, shares of ABIOMED, Inc. (ABMD) have soared 83.9%. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.

Since the first of the year, the price of Ebix, Inc. (EBIX) has swelled 106%. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.

The price of Chimera Investment Corporation (CIM) is up 329.4% since the first of the year. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock currently has a trailing PE Ratio of 5.40. For more information, get Portfolio Grader’s complete analysis of CIM stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/05/10-best-strong-buy-stocks-ipxl-ggal-stmp-and-more-ipxl-ggal-stmp/.

©2022 InvestorPlace Media, LLC